Cochrane Abstracts
First‐line combination therapy versus first‐line monotherapy for primary hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Combination Therapy Versus First‐line Monotherapy for Primary Hypertension." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433931/all/First‐line_combination_therapy_versus_first‐line_monotherapy_for_primary_hypertension.
First‐line combination therapy versus first‐line monotherapy for primary hypertension. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433931/all/First‐line_combination_therapy_versus_first‐line_monotherapy_for_primary_hypertension. Accessed January 23, 2025.
First‐line combination therapy versus first‐line monotherapy for primary hypertension. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433931/all/First‐line_combination_therapy_versus_first‐line_monotherapy_for_primary_hypertension
First‐line Combination Therapy Versus First‐line Monotherapy for Primary Hypertension [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433931/all/First‐line_combination_therapy_versus_first‐line_monotherapy_for_primary_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line combination therapy versus first‐line monotherapy for primary hypertension
ID - 433931
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433931/all/First‐line_combination_therapy_versus_first‐line_monotherapy_for_primary_hypertension
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
